Revenue
No reported data
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Research & development | $38.8M | $35.0M | $29.8M | $20.5M | $8.6M | $338,000 | $296,000 |
| Operating expenses | $60.7M | $50.3M | $41.2M | $30.6M | $15.1M | $446,000 | $310,000 |
| Operating income | −$60.7M | −$50.3M | −$41.2M | −$30.6M | −$15.1M | −$446,000 | −$310,000 |
| EBITDAderived | −$60.4M | −$50.0M | −$40.9M | −$30.5M | −$15.1M | −$446,000 | −$310,000 |
| Net income | −$48.3M | −$39.0M | −$35.6M | −$22.5M | −$9.2M | −$446,000 | −$310,000 |
| Basic EPSper diluted share | -$0.79 | -$0.75 | -$0.68 | -$0.43 | -$0.21 | -$0.02 | -$0.01 |
| Diluted EPSper diluted share | -$0.79 | -$0.75 | -$0.68 | -$0.43 | -$0.21 | -$0.02 | -$0.01 |